documents

Belantamab mafodotin (Blenrep®) Horizons Infosheet

This Horizons Infosheet contains information about belantamab mafodotin (Blenrep®) , a drug being investigated for the treatment of myeloma.

Publication date: April 2020
Last updated: October 2021
Review date: October 2022